sarizotan (EMD128130) / Newron  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sarizotan (EMD128130) / Newron
EMR 62225-006, NCT00314288: Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Completed
2
360
US, Canada, Europe, RoW
Sarizotan HCl
EMD Serono
Parkinson's Disease, Dyskinesia
 
07/03
NCT00009048: EMD 128130 for the Treatment of Parkinson's Disease

Completed
2
30
US
EMD 128130, IV Levodopa
National Institute of Neurological Disorders and Stroke (NINDS)
Parkinson's Disease
 
12/03

Download Options